ArticleCritical care (London, England)2012

Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.

Yu-Tzu Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.